Teknova | IPO Presentation Deck | 35 slides

Teknova · 2021-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

35
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
This is a standard IPO/follow-on offering summary slide.summarize
04
Uses a list of active verbs (Creating, Advancing, Delivering, Enabling, Producing, Investing, Executing) to frame company value.establish_context
05
establish_context
06
The slide uses a 2x3 grid of metrics to highlight company scale and growth.show_traction
Open slide detailBeat · Traction
07
Uses a before-after/comparison framing to contrast 'Everyone Else' with 'Teknova Production Platform'.present_solution
Open slide detailBeat · Traction
08
The slide uses a hub-and-spoke diagram to map segments and applications to the company's core offerings.present_solution
Open slide detailBeat · Traction
09
The slide uses a value-chain style process flow to segment the business into RUO (Research Use Only) and GMP (Good Manufacturing Practice) offerings.present_solution
Open slide detailBeat · Traction
10
The chart uses a broken axis for the Clinical (GMP) bar to represent the significant difference in spend.show_traction
Open slide detailBeat · Traction
11
Slide uses a combination of a growth staircase chart and a project timeline.show_traction
Open slide detailBeat · Traction
12
show_traction
Open slide detailBeat · Traction
13
The slide highlights long-term customer relationships and high growth rates within those accounts.show_traction
Open slide detailBeat · Traction
14
plan_implementation
15
transition
16
size_opportunity
Open slide detailBeat · Market Size
17
Uses a visual spectrum to illustrate the evolution of drug modalities.establish_context
Open slide detailLoop · Why Now
18
Uses a matrix-like structure to contrast processes and identify bottlenecks.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
19
The slide uses a value-chain style process diagram to illustrate product application.present_solution
Open slide detailBeat · Solution
20
Uses comparative bar charts and a product category list to establish competitive differentiation.present_solution
21
The slide uses a pie chart to show revenue concentration and a logo grid to establish social proof.show_traction
22
Uses a dual-axis bubble chart approach to show spend growth vs account distribution across a process timeline.size_opportunity
23
transition
24
The layout uses a 2x2 grid to categorize investment priorities.plan_implementation
Open slide detailLoop · Quick Win Big Bet
26
Slide highlights geographic footprint and facility specifications including ISO certifications.plan_implementation
27
plan_implementation
28
The chart uses a vertical dashed line to separate historical performance (2019-2020) from future projections (3X and 5X revenue).analyze_data
29
transition
Open slide detailBeat · Financials
30
The chart is a donut chart showing revenue distribution between Lab Essentials and Clinical Solutions.analyze_data
Open slide detailBeat · Financials
31
TTM = Trailing Twelve Months Ended March 31, 2021. Includes footnotes defining Adjusted Gross Margin and Adjusted EBITDA.analyze_data
Open slide detailBeat · Financials
32
The slide uses a simple chronological split (2019-2022 vs 2023+) to frame the transition from investment to profitability.present_solution
33
front_matter
34
Standard financial disclosure slide for EBITDA adjustments.analyze_data
35
The slide includes a footnote defining Adjusted EBITDA.analyze_data